Ova Brokers Remain Unchecked. Number of Births Resulting From In Vitro Fertilization Abroad Unknown
By Yomiuri,
The Daily Yomiuri
| 04. 30. 2012
Although Yomiuri Shimbun research indicates that at least 130 children were born to Japanese parents from 2007 to 2011 after their mothers received ova from donors overseas, the exact number is unknown because the firms that arrange the treatment are unregulated.
While an increasing number of women in Japan wish to provide ova for infertile couples, rules on the practice have not been established in Japan. This has led to a growing number of unregulated brokerages in Japan that mediate in vitro fertilization with donated ova overseas.
The brokerages introduce ova donors to couples who want to receive in vitro fertilization.
The husband's sperm is used to fertilize the donor's ova in vitro at medical institutions overseas, and the fertilized egg is implanted in the wife's uterus. The wife then returns to Japan and gives birth.
At an office in central Tokyo of a company brokering such procedures overseas, numerous photos of smiling Japanese women in their 20s are kept in thick files. They are ova donors, some of whom are Japanese women studying in the United States.
The files...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...